More SEC Filings
View Older Stories View Newer Stories-
Form 4 Inotiv, Inc. For: Feb 17 Filed by: Taylor Beth A.
-
Form 4 Voya Financial, Inc. For: Feb 17 Filed by: Keshavan Santhosh
-
Form 13F-HR BFI Wealth Solutions, For: Dec 31
-
Form 8-K CONSOLIDATED EDISON CO For: Feb 19 Filed by: CONSOLIDATED EDISON INC
-
Form 4 TWILIO INC For: Feb 17 Filed by: Viggiano Aidan
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B5 UNITIL CORP
-
Form 10-K ICU MEDICAL INC/DE For: Dec 31
-
Form 8-K Kentucky First Federal For: Feb 19
-
Form 4 BioAge Labs, Inc. For: Feb 17 Filed by: Morgen Eric
-
Form 10-K Energy Transfer LP For: Dec 31
-
Form 1-A POS BLOCKHOLD CAPITAL CORP
-
Form 4 Inotiv, Inc. For: Feb 17 Filed by: Sagartz John E
-
Form 424B5 Howmet Aerospace Inc.
-
Form 8-K Chemours Co For: Feb 19
-
Form 6-K SNDL Inc. For: Feb 19
-
Form 4 GENTEX CORP For: Feb 17 Filed by: Boehm Neil
-
Form 10-K Broadstone Net Lease, For: Dec 31
-
Form 8-K VICOR CORP For: Feb 19
-
Form 13F-HR/A T. Rowe Price Investment For: Dec 31
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4 Inotiv, Inc. For: Feb 17 Filed by: Leasure Robert Jr.
-
Form 4 COGNEX CORP For: Feb 17 Filed by: Sennett Marjorie
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4 GENTEX CORP For: Feb 17 Filed by: Ryan Scott P
-
Form 424B2 UBS AG
-
Form 1-A POS Exousia Pro, Inc.
-
Form 424B2 UBS AG
-
Form 8-K Ares Core Infrastructure For: Feb 19
-
Form D/A Cala Systems, Inc.
-
Form ABS-15G CCG Fund 1 LLC For: Dec 31
-
Form 4 EQT Corp For: Feb 17 Filed by: Knop Jeremy
-
Form D/A PERSIS CORP
-
Form 4 Voya Financial, Inc. For: Feb 17 Filed by: Toms Matthew
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 CoreCivic, Inc. For: Feb 18 Filed by: MARSHALL THURGOOD JR
-
Form 4 ZIONS BANCORPORATION, For: Feb 18 Filed by: Smith Jennifer Anne
-
Form 424B2 UBS AG
-
Form ARS SYNOPSYS INC For: Oct 31
-
Form 10-K PEABODY ENERGY CORP For: Dec 31
-
Form 424B2 UBS AG
-
Form 10-K BLUE OWL CAPITAL INC. For: Dec 31
-
Form 424B2 BofA Finance LLC
-
Form D Lowercarbon 430.5, LP
-
Form D/A Zilker Multi-Strategies
-
Form 8-K CORCEPT THERAPEUTICS For: Feb 19
-
Form 424B2 UBS AG
-
Form 4 BioAge Labs, Inc. For: Feb 17 Filed by: GOLDSTEIN DOV A MD

